Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

THRD Third Harmonic Bio, Inc.

Market Closed 12-12 16:00:00 EST

5.38

+0.00

0.00%

High5.38	Low5.38	Vol0.00
Open5.38	D1 Closing5.38	Amplitude0.00%
Mkt Cap242.79M	Tradable Cap83.95M	Total Shares45.13M
T/O0.00	T/O Rate0.00%	Tradable Shares15.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"THRD","market":"US","secType":"STK","nameCN":"Third Harmonic Bio, Inc.","latestPrice":5.38,"timestamp":1765573200000,"preClose":5.38,"halted":0,"volume":0,"delay":0,"floatShares":15603441,"shares":45127800,"eps":-1.245664,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 EST","open":5.38,"high":5.38,"low":5.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.245664,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1663214400000,"exchange":"NASDAQ","adjPreClose":5.38,"volumeRatio":0,"impliedVol":1.8287,"impliedVolPercentile":0.932},"requestUrl":"/m/hq/s/THRD/tweets","defaultTab":"tweets","newsList":[{"id":"2556867858","title":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Plans to Terminate SEC Reporting Obligations","url":"https://stock-news.laohu8.com/highlight/detail?id=2556867858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556867858?lang=en_us&edition=fundamental","pubTime":"2025-08-01 02:41","pubTimestamp":1753987270,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc. announced a regulatory development regarding its stock listing. On July 31, 2025, the company filed a Form 25 with the Securities and Exchange Commission  to voluntarily delist its common stock under Section 12 of the Securities Exchange Act of 1934. The delisting will become effective around August 10, 2025. Consequently, trading of the company's stock on Nasdaq was suspended before the market opened on July 31, 2025. Additionally, Third Harmonic Bio plans to file a Form 15 with the SEC on August 11, 2025, to terminate the registration of its common stock under Section 12 of the Exchange Act, suspending its reporting obligations. This move is part of the company's previously approved Plan of Dissolution, with a certificate of dissolution filed on the same day, July 31, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL3FXJ5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD"],"gpt_icon":0},{"id":"2553447619","title":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2553447619","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553447619?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:05","pubTimestamp":1753095948,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12 of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15 of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL8CRwXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2542532056","title":"Third Harmonic Bio Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532056","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542532056?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:06","pubTimestamp":1749672384,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc. held its 2025 Annual Meeting of Stockholders on June 5, 2025. During the meeting, several proposals were adopted. The election of three Class III directors, Thomas M. Soloway, David Bonita, M.D., and Goeff McDonough, M.D., was approved. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. The liquidation and dissolution of the Company, in accordance with the Plan of Dissolution, was approved. Additionally, the proposal to grant discretionary authority to the Board to adjourn the meeting to solicit additional proxies if needed was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL31yrdt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD"],"gpt_icon":0},{"id":"2535779224","title":"Third Harmonic Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535779224","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535779224?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:31","pubTimestamp":1747143105,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc reports results for the quarter ended March 31 - Earnings SummaryThird Harmonic Bio Inc THRD.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter ended Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1KU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD"],"gpt_icon":0},{"id":"2534430255","title":"Third Harmonic Bio Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534430255","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534430255?lang=en_us&edition=fundamental","pubTime":"2025-05-10 00:24","pubTimestamp":1746807859,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc  expected to post a loss of31cents a share - Earnings Preview Third Harmonic Bio Inc THRD.OQ THRD.O is expected to show no change in quarterly revenue when it reports  results o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD"],"gpt_icon":0},{"id":"2534198625","title":"Third Harmonic Bio Q1 EPS $(0.35) Misses $(0.29) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534198625","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534198625?lang=en_us&edition=fundamental","pubTime":"2025-05-09 05:53","pubTimestamp":1746741182,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 75 percent decrease over losses of $(0.20) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45304307/third-harmonic-bio-q1-eps-0-35-misses-0-29-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","HLIT"],"gpt_icon":0},{"id":"2533551210","title":"Optimism is Back for Biotech Stocks. This Time, It Could Last. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2533551210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533551210?lang=en_us&edition=fundamental","pubTime":"2025-05-06 02:49","pubTimestamp":1746470940,"startTime":"0","endTime":"0","summary":"Something strange has been happening with biotech stocks over the past few weeks: They have been going up.The SPDR S&P Biotech ETF, a benchmark for the sector, closed April 8 at $69.80, its worst closing price since November 2023. It was up 20% from that low by the end of the day on Friday, outperforming the S&P 500, which was up 14%. It had trounced the Health Care Select Sector SPDR ETF, which follows healthcare stocks writ large and was up 4.2%.The hope now is that the recent run-up, which began as the overall market surged after President Donald Trump delayed most of his promised tariffs by 90 days on April 9, is the first taste of a broader biotech recovery. The fear is that it is just a brief respite, driven by events outside the sector, from a selloff that will inevitably continue.Still, taking out the trash probably isn't enough to resurrect the sector. What biotech needs is to make some money, and these days that mostly means big pharma pulling out a checkbook and writing","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","LU1057294990.SGD","PFE","LU0170899867.USD","IE00BLSP4239.USD","BK4588","VOO","BK4559","SPY","SDS","BK4533","BK4550","LU0225771236.USD","LU1066053197.SGD","BK4504","LU0289739699.SGD","OEF","SG9999013999.USD","SG9999003800.SGD","ESmain","BK4592","SG9999002232.USD","BK4599","LU1066051498.USD","BK4534","LU0306807586.USD","LU1894683264.USD","OP.USD.HKCC","SG9999011175.SGD","SH","SSO","SG9999001176.SGD","FDN","LU0868494617.USD","BK4568","IE0002270589.USD","LU0058720904.USD","IVV","LU0321505439.SGD","LU0985481810.HKD","BK4007","SPXU","IE00BLSP4452.SGD",".SPX","LU0321505868.SGD","OEX","BK4585","IE000M9KFDE8.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2527268163","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2527268163","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527268163?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:48","pubTimestamp":1744634935,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) shares rose 40% in recent Monday premarket activity, after saying its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approv","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1814569148.SGD","IE0009356076.USD","LU1261432733.SGD","LU1582986359.USD","LU2602419157.SGD","MACW.SI","LU0979878070.USD","BK4550","LU1267930730.SGD","LU1674673428.USD","LU0868494617.USD","LU1066053197.SGD","IE00B19Z8X17.USD","LU0316494557.USD","LU0345770308.USD","IE0004445239.USD","LU0256863811.USD","LU2357305700.SGD","HK0000306685.HKD","SG9999014542.SGD","LU0672654240.SGD","LU1699723380.USD","BP","IE000YTNTUN2.SGD","LU1280957306.USD","PTN.AU","LU1244550494.USD","PTN","LU0957791311.USD","LU2191332357.HKD","LU2543165471.USD","BK4592","BK4507","LU0345768740.USD","VERV","BK4007","LU0256863902.USD","LU0096362180.USD","LU0553294199.USD","IE00BKVL7J92.USD","LU2462157665.USD","LU0048584097.USD","LU2065170008.USD","SG9999017495.SGD","THRD","SG9999014575.USD","LU0314104364.USD","SG9999014898.SGD","LU0889565833.HKD"],"gpt_icon":1},{"id":"2527155079","title":"Third Harmonic Seeks to Liquidate, Dissolve Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2527155079","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527155079?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:28","pubTimestamp":1744630117,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio  said Monday its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approval for the plan at its annual meeting on June 5.Under the plan, the company will wind down its operations and distribute its remaining cash to stockholders. The initial distribution will be between about $246.6 million and $255.4 million, or about $5.13 and $5.33 per share, and is expected to follow the filing of the certificate of dissolution, expected in Q3, the company said.Third Harmonics said it expects that its existing capital resources, together with the anticipated net proceeds from the sale of certain clinical assets, will enable it to meet its remaining liabilities and obligations with sufficient reserves. The company estimates that the total distribution will be between $246.6 million and $259.8 million.The estimates do not include cash that may become available for distribution from the proceeds from any sales of its remaining assets a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HLIT","BK4007","THRD","BK4020"],"gpt_icon":0},{"id":"2527155886","title":"BRIEF-Third Harmonic Bio Announces Plan Of Liquidation And Dissolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2527155886","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527155886?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:18","pubTimestamp":1744629532,"startTime":"0","endTime":"0","summary":"BRIEF-Third Harmonic Bio Announces Plan Of Liquidation And DissolutionApril 14  - Third Harmonic Bio Inc THRD.O:THIRD HARMONIC BIO INC - INITIAL DISTRIBUTION EXPECTED BETWEEN $246.6 MILLION AND $255.4 MILLION IN Q3 THIRD HARMONIC BIO ANNOUNCES PLAN OF LIQUIDATION AND DISSOLUTIONSource text: [ID:]Further company coverage: THRD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL8N3QS0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2527534521","title":"Third Harmonic Shares Surge on Liquidation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2527534521","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527534521?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:16","pubTimestamp":1744629360,"startTime":"0","endTime":"0","summary":"Shares of Third Harmonic surged on Monday after the company's board approved a liquidation plan that will pay out $5.13 to $5.33 per share.The stock was up 37% at $4.99 in premarket trading. Shares were trading for $11.52 this time a year ago.The developer of pharmaceutical products said before the bell that it will wind down operations and pay shareholders proceeds from the sales of its assets and intellectual property, including its THB335 program developing a treatment for chronic spontaneous urticaria.\"Our management team and board of directors together have completed an efficient review of our strategic alternatives for maximizing the value of our assets and have determined that returning cash to shareholders and selling our assets, including THB335, is the best path forward,\" Chief Executive Natalie Holles said.Third Harmonic said it would complete all Phase 2 readiness activities for THB335 by the middle of the year to maximize the value of the program.The initial proceeds distr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","THRD","BK4007","HLIT"],"gpt_icon":0},{"id":"2522082675","title":"Third Harmonic Bio Cut to Hold From Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2522082675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522082675?lang=en_us&edition=fundamental","pubTime":"2025-03-28 22:04","pubTimestamp":1743170640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/THRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 10:04 ET (14:04 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLIT","BK4007","SF","BK4020","THRD","BK4127"],"gpt_icon":0},{"id":"2522049520","title":"Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2522049520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522049520?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:39","pubTimestamp":1743161957,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) has an average rating of Hold and mean price target of $4.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THRD","SF","HLIT"],"gpt_icon":0},{"id":"2522355309","title":"Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522355309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522355309?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:29","pubTimestamp":1743082198,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings SummaryThird Harmonic Bio Inc THRD.OQ reported a quarterly adjusted loss of 48 cents per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA18T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD"],"gpt_icon":0},{"id":"2522537724","title":"Third Harmonic Bio FY 2024 GAAP EPS $(1.09) Beats $(1.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522537724","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522537724?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:23","pubTimestamp":1743078187,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.18) by 7.63 percent. This is a 39.74 percent decrease over losses of $(0.78) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44512541/third-harmonic-bio-fy-2024-gaap-eps-1-09-beats-1-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLIT","THRD"],"gpt_icon":0},{"id":"2522377284","title":"BRIEF-Third Harmonic Bio Q4 Net Income USD -13.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522377284","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522377284?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:20","pubTimestamp":1743078043,"startTime":"0","endTime":"0","summary":"BRIEF-Third Harmonic Bio Q4 Net Income USD -13.1 MillionMarch 27 (Reuters) - Third Harmonic Bio Inc THRD.O:THIRD HARMONIC BIO Q4 NET INCOME USD -13.1 MILLIONSource text: ID:nGNX7FfSrqFurther company coverage: THRD.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX455F5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.thirdharmonicbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.0092},{"period":"1year","weight":-0.5218},{"period":"ytd","weight":-0.4772}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.227403},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068101},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.030513},{"month":4,"riseRate":1,"avgChangeRate":0.256505},{"month":5,"riseRate":1,"avgChangeRate":0.086642},{"month":6,"riseRate":0.666667,"avgChangeRate":0.007703},{"month":7,"riseRate":0.333333,"avgChangeRate":0.132884},{"month":8,"riseRate":0,"avgChangeRate":-0.064155},{"month":9,"riseRate":0.666667,"avgChangeRate":0.075293},{"month":10,"riseRate":0.75,"avgChangeRate":0.070713},{"month":11,"riseRate":0.25,"avgChangeRate":0.016737},{"month":12,"riseRate":0.25,"avgChangeRate":-0.170618}],"exchange":"NASDAQ","name":"Third Harmonic Bio, Inc.","nameEN":"Third Harmonic Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Third Harmonic Bio, Inc.(THRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Third Harmonic Bio, Inc.,THRD,Third Harmonic Bio, Inc.股票,Third Harmonic Bio, Inc.股票老虎,Third Harmonic Bio, Inc.股票老虎国际,Third Harmonic Bio, Inc.行情,Third Harmonic Bio, Inc.股票行情,Third Harmonic Bio, Inc.股价,Third Harmonic Bio, Inc.股市,Third Harmonic Bio, Inc.股票价格,Third Harmonic Bio, Inc.股票交易,Third Harmonic Bio, Inc.股票购买,Third Harmonic Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Third Harmonic Bio, Inc.(THRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction